Dr. Avalos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 704-355-5800
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1986
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1985- Ohio State University HospitalResidency, Internal Medicine, 1980 - 1983
- Ohio State University College of MedicineClass of 1980
Certifications & Licensure
NC State Medical License 2012 - 2025
OH State Medical License 1981 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia Start of enrollment: 2013 Nov 01
- Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy Start of enrollment: 2018 Jul 13
Publications & Presentations
PubMed
- American Society of Hematology: building a comprehensive minority recruitment and retention professional program.Margo R Rollins, Rahma M Warsame, Melody Smith, Arturo Molina, Rayne H Rouce
Blood Advances. 2024-12-24 - Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplanta...Michael R Grunwald, Wei Sha, Jiaxian He, Srinivasa Sanikommu, Jonathan M Gerber
Transplantation and Cellular Therapy. 2024-12-01 - Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.Nilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, Danielle Boselli, Gray Magee
JCO Oncology Practice. 2024-11-18
Abstracts/Posters
- Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally ManagedBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Patient Reported Financial Toxicity in Myeloproliferative NeoplasmsBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic ExonBelinda R Avalos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
ASH Announces New Executive Committee Members, Hosts MDS+AML MATTER Education Program, and MoreNovember 28th, 2018
Grant Support
- G-CSF Receptor And UbiquitinationNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Loss Of Negative Signaling By The G-CSFR In AMLNational Cancer Institute2000–2002
- Loss Of Negative Signaling By The Gcsfr In AMLNational Cancer Institute1999
- G-CSFR Mutations--A Novel Mechanism Of LeukemogenesisNational Cancer Institute1997–1998
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1987–1990
- Human Erythroid-Potentiating ActivityNational Heart, Lung, And Blood Institute1986
Committees
- Member, American Society of Hematology Executive Committee 2015 - Present
- Chair, American Society of Hematology, Committee on Promoting Diversity 2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
